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Summary.-The regrowth rate of the rat sarcoma SSBla was assessed, following
treatment with either X-rays orhyperthermia. The growth rate ofuntreated tumours
implanted in pre-irradiated or pre-heated normal tissue was also measured.
For treatments giving similar levels of tumour regrowth delay, the regrowth of
irradiated tumours was markedly slower than that of untreated tumours, whilst
the regrowth rate of tumours subjected to hyperthermia did not differ from that of
untreated tumours. The growth rate ofuntreated tumours implanted in pre-irradia-
ted skin was also slower than that of controltumours, thoughthe growth-rate reduc-
tion was less dramatic than for regrowth following tumour irradiation in situ.
Tumours implanted in pre-heated skin grew at the same rate as control tumours.
Slower regrowth in situ after X-rays than after hyperthermia would produce a
larger growth delay for X-rays than for hyperthermia, for equal levels of tumour-
cell kill or probability of tumour sterilization. This effect could lead to a systematic
underestimation of the efficacy of hyperthermia relative to X-rays, when efficacy is
assessed by growth delay.
IN COMPARING the relative effectiveness
of different treatments, using regrowth
delay as the end-point, it is important
to determine, if possible, the contribu-
tion made by factors other than cell
survival-especially if the relative con-
tributions may differ from one modality
to another. Regrowth delay as a tumour
response results from (a) the level of
cell survival and (b) the rate at
which the surviving cells regrow. Each
of these components may be affected
by treatment, and the interpretation of
regrowth-delay experiments is compli-
cated by the possibility that kinetic
changes induced by the treatment play
a significant role in the observed response
(see Brown & Howes, 1974; McNally,
1974).
In the present report, a comparative
study is made of growth changes in
kinetics induced by X-rays or hyper-
thermia. A growth-slowing effect of
irradiation is well recognized and may
result, at least in part, from vascular
damage to the normal tissues which
constitute the tumour bed (Stenstrom
et al., 1955; Summers et al., 1964; Thom-
linson & Craddock, 1967; Hewitt &
Blake, 1968). "Tumour-bed effect" is
sometimes used to describe the slowed
growth of Ltumours which have been
irradiated in situ, as well as that of
untreated tumours growing in pre-treated
normal tissues. However, in this report,
we shall restrict "tumour-bed effect" to
mean growth-rate changes which result
from treatment of normal tissue only
(as when untreated tumours are implanted
in pre-treated normal tissues) and shall
use "slowed regrowth in situ" to describe
growth-rate changes which may be ob-
served when the tumour and its support-
ing normal tissues both receive treatment.T. E. WHELDON AND E. C. HINGSTON
MATERIALS AND METHODS
The tumour used in these experiments was
the rat fibrosarcoma SSBIa, the biological
properties of which have been described
previously (Howlett et al., 1975). The
tumour arose spontaneously in a John's
Wistar rat, but was subsequently propagated
in Wistar/CFHB hybrid rats, which were
the animals used in the experiments described
here. The immunological status ofthis tumour
system has not been thoroughly investigated,
but the transplantation "take rate" averaged
95% in > 1000 transplantations, and no
spontaneous regressions were recorded. All
tumours were implanted s.c. in the form of
1mm cubes in the mid-dorsal region, just
to one side of the mid-line, while the rat
was under ether anaesthesia. The incision
was closed with a Michel surgical clip which
was removed 3 days later. Typically, tumours
became palpable 6-10 days after implanta-
tion, and were thereafter measured 3 times
a week, in 3 mutually perpendicular dimen-
sions, using calipers. Animals were assigned
to treatment groups when the geometric
mean diameter of the tumour was within
the range 7-10 mm. Tumours attached to the
skin were discarded. In all experiments, both
male and female rats were used, in roughly
equal proportions.
Anaesthesia.-In all treatment procedures,
the rats were anaesthetized by i.p. injection
of a neuroleptanalgesic mixture (Hypnorm,
Crown Chemical Co.) at a dose level of 1
ml/kg for males, reduced by 8% for females
(see Green, 1980). After treatment, recovery
was accelerated by administration of a
Naloxone antidote (Narcan Neonatal, Win-
throp Labs) at a dose level of 0x2 ml/kg.
X-irradiation.-When the animals were
fully anaesthetized, 2 sutures were passed
through the dorsal skin, inferior and superior
to the tumour. The rat was placed prone on a
jig with an overhead strut and each suture
was tied to the strut, thus pulling the tumour
and surrounding skin well clear of the verte-
brae.
X-irradiation was carried out using a
250kV Marconi X-ray set (filtration: 0 3
mm Cu, 1 mm Al; half-value layer: 1-35 mm
Cu). The tumour, supported by the sutures,
was placed flush with the collimator and the
X-rays were delivered horizontally at a dose
rate of 3.75 Gy/min. Animals were irradiated
individually and turned throughx 180' half-
way through the irradiation to improve the
dose uniformity. The estimated dose varia-
tion within the tumour was <4% and the
total-body dose, mainly due to internal
scatter, was <3%. Each dose group used
6-10 animals.
For irradiation of the tumour bed before
transplantation, the procedure was very
similar to that described above, but animals
were treated before tumour transplantation,
so that only the skin and associated normal
tissues were irradiated.
After treatment, the perimeter of the
treated area was clearly marked by painting
with picric acid, and tumours were then
implanted within the treated region, within
24 h of treatment. The developing tumours
were measured as described previously.
Tumours which grew outside the treatment
area, or were attached to muscle, were
discarded from the study. In each dose group,
6-10 animals were used, and of these about
one-third (on average) were discarded because
of outside growth or attachment.
Hyperthermia.-Hyperthermia treatment
was carried out with the tumours rendered
hypoxic by mechanical clamping to eliminate
blood flow and facilitate uniform heating.
This was found (in a previous study) to
improve uniformity of the regrowth delay.
However, clamping without heating had no
effect on tumour growth, and induced no
additional regrowth delay.
For these studies, the tumour and sur-
rounding skin was pulled away from the
vertebrae and passed through a slot (1 of 6)
cut in a plastic tray. The tumour and skin
were then firmly clamped between two
sections of a plastic clamp, which was
tightened with a screw.
When all 6 rats had been positioned below
the tray, the tray was inverted so that the
rats lay on top in a supine position, with the
clamped tumours protruding beneath the
slots. The tray was then fitted on to a preci-
sion-controlled circulating water-bath (ac-
curacy±0-05TC) at a pre-set temperature of
43 5'C, with the clamped tumours immersed,
but the bodies of the rats well clear of the
water.
In a separate study, thermocouple probes
were inserted into the tumour and found to
stabilize at a temperature 0 2-0 5°C below
the temperature of the water-bath, within
2-4 min of immersion. However, it is not
possible to exclude the existence of isolated
"cold spots" within the tumour.
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For each treatment time, 12-20 animals
per group were used.
For effects on the tumour bed, clamped
dorsal skin was heated before tumour
implantation. After heating, the clamps were
removed and the perimeter of the treated
area marked with picric acid. Within 24 h
of treatment, tumour implantation was
carried out and the implanted tumour placed
close to the centre of the treated region. The
tumours were then measured as before,
discarding from the study those tumours
which grew outside the treated area or were
attached to muscle.
For each treatment time, 12-20 animals
were used per group and, of these, about
one-quarter were discarded from the study.
Growth-curve analysis. Growth curves
were plotted and analysed for each tumour
individually. This was considered necessary
because composite growth curves bias in
favour of slow growing tumours (whose host
animals are killed later) (see Begg, 1980).
Within the size range 5-20 mm geometric-
mean diameter, individual growth curves
conformed well to an exponential increase of
mean diameter with time; Gompertz retarda-
tion becoming apparent only at larger sizes.
This was true both for untreated tumours
and for tumours regrowing after X-rays or
hyperthermia. Tumours recurrent after X-
rays or hyperthermia usually followed ex-
ponential regrowth patterns.
Growth rates were quantified by fitting the
equation
ln [diameter -=p [time since treatment]
+constant
to growNth data for each individual tumour,
using the method of least squares. Then the
quantity p. provides a measure of the rate
of growth of each individual tumour and the
arithmetic mean i for a group of tumours
provides a measure of the average growth
rate for this group.
For untreated (control) tumours, individual
growth rates were calculated within the size
range of geometric mean diameter 7-20 mm.
For tumours recurrent after X-irradiation,
the preceding rule was applied, with the
proviso that analysis was confined to the
monotonic ascending limb of the growth
curve (i.e. regression phase and "static"
phase were excluded from the analysis). For
tumours recurring after hyperthermia, a
period of transient oedema invariably fol-
lowed, and analysis was therefore confined
to the post-oedema phase of regrowth.
Tumour growth was usually analysable only
within the size region 10-20 mm mean
diameter. Within this region, exponential
growth was again observed for the great
majority of recurrent tumours.
RESULTS
Fig. 1 shows the relationship between
the regrowth time (time to grow to 15
mm geometric-mean diameter) and
severity of treatment, for X-ray doses up
to 30 Gy and for hyperthermia treatment
(43 5°C water-bath) up to 60 min.
As may be seen, the hyperthermia
dose-response curve is approximately
linear, whilst the X-irradiation dose-
response curve has a more coinplex
shape.
Fig. 2 shows the relationship between
the mean growth rate (f) defined pre-
viously, and severity of treatment, for
X-rays and hyperthermia.
For hyperthermia, the growth rates
show no simple relationship to severity
of treatment, but remain close to the
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FIG. 1. Regrowth delay (time to grow from
treatment size to 15 mm mean diameter)
for X-irradiation (0 0 *) and for hyper-
thermia treatment time at 43*5°C
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Fig. 2. Mean specific exponential regrowth
rate (,) in situ for tumours regrowing
(within the size range 7-20 mm diameter)
after X-irradiation (0 0*) or hyper-
thermia (0 ---0).
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FIG. 3.-Mean specific exponential growth
rate (,t) for untreated tumours growing in
sites previously treated with X-rays
(0 0 *) or hyperthermia (0 ---0).
TABLE.-Summary of in situ responses and tumour-bed effects for X-rays and
hyperthermia, using the rat fibrosarcoma SSBla
X-irradiation
Tumour-bed
Regrowth in situ effect
Specific Specific T
Growth growth growth
delay rate (,) rate (,u) 4
(days) (In mm/day) (In mm/day)
5-91+0 44 0-106+0-003 0-106+0-003
5 44+0 34 0-079+0-008 0-096+0-006
8-99+0-84 0-055+0-006 0-090+0-017
10-18+0-80 0-059+0-008 0-075+0-013
11-61+0 90 0 059+0 007 0-084+0-006
22-50+4-77 0-046+0-005 0 074+0 004
23-10+6-35 0-063+0-007 0-083+0-007
Hyperthermia
rime
at
L3 50C
(min)
0
10
20
30
45
52
Tumour-bed
Regrowth in situ effect
Specific Specific
Growth growth growth
delay rate (tt) rate (,u)
(days) (In mm/day) (In mm/day)
5-91+0-44 0-106+0-003 0-106+0-003
9 03+0 50 0-096+0-004 0-108+0-005
9-73+0-60 0-114+0-005 0-102+0-006
13-94+ 1-16 0-128+0-006 0-110+0-006
18-54+1-47 0-099+0-007 0-101+0-004
21-48+ 1-78 0-110+0-014
Notes (1) All means are given + s.e.
(2) Statistical analysis used the Wilcox-Mann-Whitney U test to assess the significance of the
difference between mean growth rates for both X-rays and hyperthermia. This analysis showed
that:
(a) The mean regrowth rate in situ after X-rays (5-30 Gy) is significantly different from
the regrowth rate after hyperthermia (10-52 min) (P < 0 -01).
(b) The corresponding growth rates in tumour-bed effect experiments also differed significantly
(P < 0 *01).
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FIG. 4.-Possible consequences of a differential regrowth rate after different forms of treatment. Treat-
ment B produces the lower cell survival but (because of fast regrowth), the shorter growth delay.
the growth rate is about half the corres-
ponding value for untreated tumours.
Fig. 3 shows the relationship of growth
rate to severity of treatment for un-
treated tumours implanted in previously
treated normal tissues. As with regrowth
in situ, for X-irradiation, the growth rate
initially declines with treatment, plateau-
ing (above 10 Gy) at a growth rate about
three-quarters ofthat for control tumours.
For hyperthermia, the growth rate again
simply scatters around the mean for
control tumours, with no obvious effect
of severity of treatment.
In addition to the graphical presenta-
tions in Figs. 1-3, the results of these
experiments are summarized in the Table.
DISCUSSION
The results presented show that, for
similar levels of growth delay, tumours
regrow more slowly after X-irradiation
than after hyperthermia. In addition,
tumours implanted in pre-irradiated nor-
mal tissue grow more slowly than tumours
implanted in pre-heated tissue.
The latter finding agrees with that
reported by Urano & Cunningham (1980);
i.e. a significant tumour-bed effect for
X-irradiation but not for hyperthermia.
However, these authors compared treat-
ments giving equivalent effects on normal
skin (as assessed by skin scoring) rather
than equivalent anti-tumour effects, and
did not assess regrowth in situ.
Slowed regrowth in situ after X-irradia-
tion is well recognized (Suit & Shalek,
1963; Thomlinson & Craddock, 1967;
Hawkes et al., 1968). Less uniform and
more erratic growth patterns have also
been reported (Brown & Howes, 1974;
Abdelaal et al., 1980) though this was not
the case in the present study.
The tumour-bed effect, which may be
partly responsible for slowed growth
in situ, is also well known (Stenstrom
et al., 1955; Summers et al., 1964; Hewitt
& Blake, 1968; Urano & Suit, 1971)
and may result from a reduced capacity
269
I2T. E. WHELDON AND E. C. HINGSTON
of the irradiated tumour bed to provide
adequate vascularization for the growing
tumour (Thomlinson & Craddock, 1967;
Clifton & Jirtle, 1975; Jirtle et al., 1978).
If vascular incapacity is responsible
for the tumour-bed effect, it is perhaps
surprising that this effect should not
occur after hyperthermia, since vascular
damage has been reported for hyper-
thermia treatments within the range
reported here (Falk, 1980; Song et al.,
1980). However, the relevant factor may
be the ability of the treated tissue to
respond to tumour demands for neo-
vascularization rather than the functional
competence ofexisting vascular structures.
Alternatively, early expression of cellular
damage by hyperthermia (e.g. inter-
mitotic cell death) could lead to earlier
tissue recovery and repopulation after
hyperthermia than after radiation, for
which damage may remain latent until
cell division is provoked by the vascular
demands of the developing tumour.
Since the observed regrowth delay
depends both upon the number of
clonogenic tumour cells surviving treat-
ment and upon the rates at which these
surviving cells repopulate, treatment-
induced growth changes may have a
marked effect on the resultant growth
delay. An extreme example is schemati-
cally illustrated in Fig. 4. This shows how,
in principle, a differential effect on
regrowth kinetics could lead to a reversal
of the order of effectiveness of the two
modalities; i.e. the modality with the
lesser cell kill but the slower regrowth
being judged "more effective" (in terms
of growth delay) than the modality
giving greater cell kill but rapid re-
growth. More generally, a differential
effect on regrowth kinetics will lead to a
divergence of the growth delay assay
from those based on clonogenic cell
survival, the modality giving the faster
regrowth being systematically under-
valued.
Whether or not the effects described
in this paper occur during the initial
repopulation phase of cells is not known.
Even for X-irradiation, the size range
over which the tumour-bed effect occurs
is by no means clear. Theoretically, it
may be expected that the effect would
be confined to the "vascular" phase of
tumour growth (i.e. macroscopic sizes)
and this expectation is supported by the
study of Hewitt & Blake (1968), who
found no effect of tumour-bed irradiation
on the latent period for development of
tumours from implanted cells to the
point of detectability. By contrast, Urano
& Suit (1971) and Abdelaal et al. (1980)
observed a significant prolongation of
latency (albeit with a larger end-point)
as well as a slowed growth of macro-
scopic tumours.
Whether the tumour-bed effect is exclu-
sively responsible for slowed regrowth in
situ, or is only one component, is not
known. Theoretically, surviving cells re-
growing in situ are in a very different
environment from cells implanted in an
irradiated tumour bed (e.g. the pre-
existence of tumour blood vessels in the
former). However, Hewitt & Blake (1968)
demonstrated a tumour-bed effect in
sites of tumours irradiated in situ, whilst
Abdelaal et al. (1980) implanted cells
both in irradiated (non-tumour-bearing)
normal tissue and in the sites of tumours
previously cured by irradiation, and
observed similar growth slowing in both
cases. These results are consistent with
slowed regrowth in situ being largely or
wholly due to a tumour-bed effect.
However, Abdelaal et al. (1980) also
noted a severe non-uniformity for re-
growth in situ which did not occur for
tumours developing in pre-irradiated
normal tissue, indicating some differences
between the two situations.
In the present series of experiments,
growth and regrowth patterns remained
reasonably uniform throughout, but the
reduction of overall growth rate was
appreciably greater for regrowth in situ
than for tumours implanted into pre-
irradiated normal tissues. It seems pos-
sible that while the tumour-bed effect
makes an important contribution to
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slowed regrowth in situ, additional factors
(e.g. sublethal damage to tumour cells)
may also contribute.
Since changes in growth kinetics are a
principal obstacle to the estimation of
cell survival in situ by back-extrapolation
of regrowth curves (see Denekamp, 1980;
Wheldon, 1980), the apparent absence
of such effects for hyperthermia could
make in situ estimates of cell survival
more feasible for this modality than for
others.
It is possible that some of the differ-
ences noted here for X-irradiation or
hyperthermia may be due to different
cells being sensitive or resistant to each
of the two modalities (e.g. hyperthermia
may preferentially kill cells resistant to
radiation) so that similar regrowth pat-
terns would not necessarily follow treat-
ments which are iso-effective for cell
kill. However, the implications of such
a possibility have seldom been considered.
Finally, it should be noted that different
kinetic effects of treatment may occur
for different cytotoxic drugs, as well as
for the treatment modalities reported
here (see Stephens & Peacock, 1977;
Peacock & Stevens 1978). Evaluation of
the magnitude of such treatment-induced
kinetic changes is necessary for confident
interpretation of regrowth delay experi-
ments, especially where more than one
treatment modality is involved.
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